ReviewAnnals of medicine2024

Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.

Honghu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.